Inflexion to Sell Celnor Stake to Goldman Sachs
Private equity firm Inflexion has agreed to sell its majority stake in British testing and compliance company Celnor Group to Goldman Sachs Alternatives in a deal valuing the firm at one billion euros. Inflexion will retain a minority stake as Celnor seeks to expand further in the United States and Continental Europe.
Xurve View
Insights:
Xurve View
Inflexion agreed to sell a majority stake in testing and safety compliance firm Celnor Group to GOLDMAN SACHS GROUP INC on Friday morning, valuing the company at €1 billion ($1.12 billion). The transaction allows Inflexion to retain a minority stake in the British firm it helped establish in 2023. GOLDMAN SACHS GROUP INC will provide capital to accelerate Celnor's international expansion and acquisition strategy.
